122 related articles for article (PubMed ID: 36262039)
1. Local ablation of hepatocellular carcinoma by interstitial brachytherapy: prediction of outcome by diffusion-weighted imaging.
Thormann M; Surov A; Pech M; March C; Hass P; Damm R; Omari J
Acta Radiol; 2023 Apr; 64(4):1331-1340. PubMed ID: 36262039
[TBL] [Abstract][Full Text] [Related]
2. Interstitial Brachytherapy of the Liver for Renal Cell Carcinoma: ADC Measurements Do Not Predict Overall Survival.
Thormann M; Heitmann F; Wrobel V; March C; Pech M; Surov A; Damm R; Omari J
In Vivo; 2022; 36(6):2945-2951. PubMed ID: 36309358
[TBL] [Abstract][Full Text] [Related]
3. Interstitial Brachytherapy for Hepatocellular Carcinoma: Analysis of Prognostic Factors for Overall Survival and Progression-Free Survival and Application of a Risk Stratification Model.
Thormann M; Heitmann F; Wrobel V; Heinze C; March C; Hass P; Damm R; Surov A; Pech M; Omari J
Dig Dis; 2023; 41(6):957-966. PubMed ID: 37385234
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma.
Karim H; Thormann M; Omari J; Surov A; Schinner R; Seidensticker R; Ingenerf M; Ricke J; Schmid-Tannwald C
Acta Radiol; 2024 Jan; 65(1):14-22. PubMed ID: 36843430
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation.
Labeur TA; Runge JH; Klompenhouwer EG; Klümpen HJ; Takkenberg RB; van Delden OM
Abdom Radiol (NY); 2019 Aug; 44(8):2740-2750. PubMed ID: 31069479
[TBL] [Abstract][Full Text] [Related]
6. Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodules.
Heinze C; Damm R; Othmer M; Thormann M; Surov A; Hass P; Seidesticker R; Seidensticker M; Ricke J; Powerski M; Pech M; Omari J
Brachytherapy; 2023; 22(2):231-241. PubMed ID: 36697267
[TBL] [Abstract][Full Text] [Related]
7. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative ADC predicts early recurrence of HCC after curative resection.
Lee S; Kim SH; Hwang JA; Lee JE; Ha SY
Eur Radiol; 2019 Feb; 29(2):1003-1012. PubMed ID: 30027408
[TBL] [Abstract][Full Text] [Related]
9. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging.
Rhee TK; Naik NK; Deng J; Atassi B; Mulcahy MF; Kulik LM; Ryu RK; Miller FH; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 Aug; 19(8):1180-6. PubMed ID: 18656011
[TBL] [Abstract][Full Text] [Related]
10. One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.
Barat M; Fohlen A; Cassinotto C; Jannot AS; Dautry R; Pelage JP; Boudiaf M; Pocard M; Eveno C; Taouli B; Soyer P; Dohan A
J Magn Reson Imaging; 2017 Jun; 45(6):1648-1658. PubMed ID: 27766709
[TBL] [Abstract][Full Text] [Related]
11. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Carcinoma: In Vivo Evaluation of Water Percentage as a Prognostic Biomarker Using Magnetic Resonance Imaging 3D-VIBE Multiecho Dixon.
Wang M; Yuan F; Wei Y; Xia C; Hu F; Song B
Cancer Biother Radiopharm; 2018 Sep; 33(7):300-306. PubMed ID: 30109954
[TBL] [Abstract][Full Text] [Related]
13. Correlations between the minimum and mean apparent diffusion coefficient values of hepatocellular carcinoma and tumor grade.
Li X; Zhang K; Shi Y; Wang F; Meng X
J Magn Reson Imaging; 2016 Dec; 44(6):1442-1447. PubMed ID: 27228086
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma.
Song Z; Ye J; Wang Y; Li Y; Wang W
J Cancer Res Ther; 2019; 15(7):1553-1560. PubMed ID: 31939437
[TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area.
Faron A; Sprinkart AM; Pieper CC; Kuetting DLR; Fimmers R; Block W; Meyer C; Thomas D; Attenberger U; Luetkens JA
Eur J Radiol; 2020 Apr; 125():108889. PubMed ID: 32087468
[TBL] [Abstract][Full Text] [Related]
16. Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.
Kokabi N; Camacho JC; Xing M; Qiu D; Kitajima H; Mittal PK; Kim HS
Abdom Imaging; 2014 Oct; 39(5):969-78. PubMed ID: 24740759
[TBL] [Abstract][Full Text] [Related]
17. Volumetric quantitative histogram analysis using diffusion-weighted magnetic resonance imaging to differentiate HCC from other primary liver cancers.
Lewis S; Peti S; Hectors SJ; King M; Rosen A; Kamath A; Putra J; Thung S; Taouli B
Abdom Radiol (NY); 2019 Mar; 44(3):912-922. PubMed ID: 30712136
[TBL] [Abstract][Full Text] [Related]
18. Prediction of hepatocellular carcinoma response to
Gordic S; Wagner M; Zanato R; Hectors S; Besa C; Kihira S; Kim E; Taouli B
Cancer Imaging; 2019 May; 19(1):29. PubMed ID: 31142363
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
20. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
